Difference between revisions of "Transformation of PGD2 to PGJ2"
(→Parameters) |
|||
Line 16: | Line 16: | ||
== Parameters == | == Parameters == | ||
− | {|class="wikitable" | + | |
− | + | {|class="wikitable sortable" | |
+ | |+ style="text-align: left;" | Association Rate Constant (Kf) | ||
+ | |- | ||
! Value | ! Value | ||
! Units | ! Units | ||
− | ! | + | ! Conditions |
+ | ! Substrate | ||
! Reference | ! Reference | ||
|- | |- | ||
Line 28: | Line 31: | ||
| A | | A | ||
| B | | B | ||
+ | |} | ||
+ | |||
+ | {|class="wikitable sortable" | ||
+ | |+ style="text-align: left;" | Dissociation Rate Constant (Kr) | ||
+ | |- | ||
+ | ! Value | ||
+ | ! Units | ||
+ | ! Conditions | ||
+ | ! Substrate | ||
+ | ! Reference | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | {|class="wikitable sortable" | ||
+ | |+ style="text-align: left;" | Dissociation Constant | ||
+ | |- | ||
+ | ! Value | ||
+ | ! Units | ||
+ | ! Conditions | ||
+ | ! Substrate | ||
+ | ! Reference | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
|} | |} | ||
== Related Reactions == | == Related Reactions == | ||
* [[Transformation of PGJ2 to 15-D-PGJ2 |Transformation of PGJ2 to 15-D-PGJ2]] | * [[Transformation of PGJ2 to 15-D-PGJ2 |Transformation of PGJ2 to 15-D-PGJ2]] |
Revision as of 09:55, 3 April 2017
Due to the lack of PGD2 production by keratinocyte and fibroblast cells, the anti-inflammatory cyclopentanones, PGJ2 and 15d-PGJ2, will not be produced during early experimental procedures either.
Reaction
Chemical equation
Rate equation
Parameters
Value | Units | Conditions | Substrate | Reference |
---|---|---|---|---|
X | Y | Z | A | B |
Value | Units | Conditions | Substrate | Reference |
---|---|---|---|---|
Value | Units | Conditions | Substrate | Reference |
---|---|---|---|---|